Article Text

Download PDFPDF
Radiographic progression in children with polyarticular juvenile rheumatoid arthritis: a pilot study
  1. T Mason1,
  2. A M Reed1,
  3. A M Nelson2,
  4. K B Thomas3
  1. 1Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
  2. 2Division of Rheumatology, Mayo Clinic College of Medicine
  3. 3Division of Radiology, Mayo Clinic College of Medicine
  1. Correspondence to:
    Dr Tom Mason
    Division of Rheumatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA; mason.thomasmayo.edu

Abstract

Objective: To assess disease progression on hand/wrist x rays from children with polyarticular juvenile rheumatoid arthritis.

Methods: Initial and subsequent films of 13 white children (10 girls) were read blind by a paediatric radiologist for the presence of joint space narrowing (JSN), erosions, and relative carpal length (RCL).

Results: One child had subcutaneous nodules; one (of 11) was rheumatoid factor positive; six were ANA positive. Median age at diagnosis was 10.7 years (2.5 to 15.9). Median number of involved joints (swelling, pain, or decreased range of motion) at diagnosis was 16 (6 to 33). Four initial x rays had either erosions or JSN. Subsequent x rays were done at (median) 13.3 (8.3 to 24.9) months after initial x rays. One of 10 subsequent x rays had shortened RCL, and six of 13 were worse than the initial ones. Four of these developed new erosions, one had increased number of erosions, and one developed new JSN.

Conclusions: About half the children with polyarticular juvenile rheumatoid arthritis will have evidence of radiographic progression within two years after diagnosis. Thus newly diagnosed children are at high risk of substantial joint destruction and potential disability, emphasising the need for prompt treatment.

  • DMARD, disease modifying antirheumatic drug
  • JSN, joint space narrowing
  • RCL, relative carpal length
  • juvenile rheumatoid arthritis
  • radiographic progression

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • This work was supported by the Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.